Calcipotriol betam ethasone ointment and Halometasone Cream in the treatment of vitiligo vulgaris: a self-controlled, parallel group study

Status

Active, not recruiting

Phases

Phase 1

Study type

Interventional

Source

ChiCTR

Registry ID

ChiCTR-TRC-11001639

Enrollment

Unknown

Registered

2011-10-24

Start date

2011-10-31

Completion date

Unknown

Last updated

2017-04-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

vitiligo

Interventions

2:topical application

Eligibility

Sex/Gender

All

Age

18 Years to 80 Years

Inclusion criteria

Inclusion criteria: vitiligo vulgaris 18-60 years old

Exclusion criteria

Exclusion criteria: segmental vitiligo

Design outcomes

Primary

Measure	Time frame
VAS;	—

Countries

China

Contacts

Public ContactTianwen Gao

gaotw@fmmu.edu.cn+86 29 84775401

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026